Found: 1
Select item for more details and to access through your institution.
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1213, doi. 10.1093/neuonc/noae033
- By:
- Publication type:
- Article